Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
Am J Respir Crit Care Med. 2015 Jul 1;192(1):117-8. doi: 10.1164/rccm.201504-0747LE.
Am J Respir Crit Care Med. 2015.
PMID: 26131996
No abstract available.
What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?
Bastard M, Sanchez-Padilla E, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Fadul Perez S, Telnov A, Hewison C, Varaine F, Bonnet M.
Bastard M, et al. Among authors: kimenye k.
Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1060-1067. doi: 10.5588/ijtld.18.0649.
Int J Tuberc Lung Dis. 2019.
PMID: 31627770
Item in Clipboard
Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?
Bastard M, Bonnet M, du Cros P, Khamraev AK, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Telnov A, Sanchez-Padilla E, Hewison C, Varaine F.
Bastard M, et al. Among authors: kimenye k.
Am J Respir Crit Care Med. 2015 Feb 1;191(3):355-8. doi: 10.1164/rccm.201407-1302LE.
Am J Respir Crit Care Med. 2015.
PMID: 25635495
No abstract available.
Item in Clipboard
Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
Bastard M, Sanchez-Padilla E, du Cros P, Khamraev AK, Parpieva N, Tillyashaykov M, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Perez SF, Telnov A, Hewison C, Varaine F, Bonnet M.
Bastard M, et al. Among authors: kimenye k.
PLoS One. 2018 Mar 8;13(3):e0193491. doi: 10.1371/journal.pone.0193491. eCollection 2018.
PLoS One. 2018.
PMID: 29518098
Free PMC article.
Item in Clipboard
Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
Bonnet M, Bastard M, du Cros P, Khamraev A, Kimenye K, Khurkhumal S, Hayrapetyan A, Themba D, Telnov A, Sanchez-Padilla E, Hewison C, Varaine F.
Bonnet M, et al. Among authors: kimenye k.
Int J Tuberc Lung Dis. 2016 Feb;20(2):177-86. doi: 10.5588/ijtld.15.0962.
Int J Tuberc Lung Dis. 2016.
PMID: 26792469
Item in Clipboard
In reply.
Kosgei RJ, Sitienei JK, Kipruto H, Kimenye K, Gathara D, Odawa FX, Gichangi P, Callens S, Temmerman M, Sitienei JC, Kihara AB, Carter EJ.
Kosgei RJ, et al. Among authors: kimenye k.
Int J Tuberc Lung Dis. 2016 Mar;20(3):425-6. doi: 10.5588/ijtld.15.1031-2.
Int J Tuberc Lung Dis. 2016.
PMID: 27046730
No abstract available.
Item in Clipboard
Gender differences in treatment outcomes among 15-49 year olds with smear-positive pulmonary tuberculosis in Kenya.
Kosgei RJ, Sitienei JK, Kipruto H, Kimenye K, Gathara D, Odawa FX, Gichangi P, Callens S, Temmerman M, Sitienei JC, Kihara AB, Carter EJ.
Kosgei RJ, et al. Among authors: kimenye k.
Int J Tuberc Lung Dis. 2015 Oct;19(10):1176-81. doi: 10.5588/ijtld.15.0070.
Int J Tuberc Lung Dis. 2015.
PMID: 26459529
Item in Clipboard
Cite
Cite